Do Nonsteroidal Antiinflammatory Drugs Reduce the Risk of Alzheimer's Disease?
- 22 November 2001
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 345 (21) , 1567-1568
- https://doi.org/10.1056/nejm200111223452110
Abstract
In this issue of the Journal, in 't Veld and colleagues1 report the results of a long-term prospective study of the relation between the use of nonsteroidal antiinflammatory drugs (NSAIDs) and the onset of Alzheimer's disease. This important article appears to resolve puzzling conflicts among the results of prior studies of the possible neuroprotective effects of NSAIDs.The dementia of Alzheimer's disease has an insidious onset and a gradually progressive course. Although the pathogenesis of the disease remains controversial, the process is widely thought to begin in midlife or earlier, decades before the appearance of symptoms. At that point, largely . . .Keywords
This publication has 14 references indexed in Scilit:
- Nonsteroidal Antiinflammatory Drugs and the Risk of Alzheimer's DiseaseNew England Journal of Medicine, 2001
- Mild Cognitive Impairment Represents Early-Stage Alzheimer DiseaseArchives of Neurology, 2001
- Mild Cognitive ImpairmentArchives of Neurology, 1999
- NSAIDs and incident Alzheimer’s disease. the Rotterdam studyNeurobiology of Aging, 1998
- Nonsteroidal Anti-Inflammatory Drug Use and Alzheimer's Disease: A Case-Control Study in Rochester, Minnesota, 1980 Through 1984Mayo Clinic Proceedings, 1998
- Risk of Alzheimer's disease and duration of NSAID useNeurology, 1997
- Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's diseaseNeurology, 1996
- Apolipoprotein E and cognitive decline in Alzheimer's diseaseNeurology, 1996
- The inflammatory response system of brain: implications for therapy of Alzheimer and other neurodegenerative diseasesBrain Research Reviews, 1995
- Education and the prevalence of dementia and Alzheimer's diseaseNeurology, 1993